insights_auto
Why is ABVX down ၃.၁၁%?
Dive Deeperchevron_right
ABVX:EPA
Abivax SA
၈၀.၉၀ €
arrow_downward
-၃.၁၁%(-၂.၆၀) 1D
အောက် ၅, GMT+၂ ၁၇:၃၅:၂၁ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၇၉.၈၅ €
Mkt. cap
၇၂၅.၁၄ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၀.၀၀
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၇၉.၈၅ €
Mkt. cap
၇၂၅.၁၄ ဋေ
Avg. vol.
၁.၅၇ သိန်း
Volume
၀.၀၀
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
Does One Year DM1 Trial Data Change The Bull Case For Dyne Therapeutics Stock?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
The Bond Market Just Sent Investors a Warning. Here's the Mistake I'd Avoid Making With the S&P 500.
GreenevilleSun.com
·
ပြီးခဲ့သည့် ၁ နာရီ
US stocks rise to the edge of an all-time high
CNBC
·
ပြီးခဲ့သည့် ၄ နာရီ
Tuesday's big stock stories: What’s likely to move the market in the next trading session
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com